Warsaw Stock Exchange/ PLGPW0000017 /
| 2024-06-06 7:57:31 AM | Chg. -0.2600 | Volume | Bid9:52:52 PM | Ask9:52:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.8400EUR | -2.34% | - Turnover: - |
10.6800Bid Size: 380 | 11.1000Ask Size: 380 | 449.78 mill.EUR | - | - |
GlobeNewswire
05-28
Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumou...
GlobeNewswire
05-21
Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatmen...
GlobeNewswire
04-04
PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Tre...
GlobeNewswire
04-03
Molecure has published its financial report for 2023 - the company has significantly accelerated the...
GlobeNewswire
03-22
First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis
GlobeNewswire
03-11
PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing ...
GlobeNewswire
01-30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
01-16
PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes
GlobeNewswire
2023-12-11
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
2023-12-07
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
2023-11-29
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-10-31
Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights
GlobeNewswire
2023-10-23
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
2023-10-04
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
2023-09-29
Molecure Announces First Half 2023 Results – Significant Financial and Operating Momentum
GlobeNewswire
2023-09-13
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
Newsfile Corp
2022-08-08
Monaco Foundry Partners with Carlson Investments SE (Carlson VC), a Publicly Listed Venture Capital ...
GlobeNewswire
2021-09-24
Getka and Unimot to Power Projects in Poland with American-Made Solar Panels from First Solar
euro adhoc
2021-09-20
EANS-Tip Announcement: Raiffeisen Centrobank AG / Half-year financial report according to art. 125 p...
GlobeNewswire
2021-06-22
Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in ...
GlobeNewswire
2021-06-07
Mkango to Create European Rare Earths Hub in Poland With Grupa Azoty Pulawy, Poland’s Leading Fertil...
GlobeNewswire
2021-04-19
Celon Pharma Hosting a Virtual Capital Markets Day on Wednesday, April 21st
